Associations Between Preconception Weight Loss Drug Use, Gestational Weight Gain, and Development of Gestational Diabetes

Background: Weight loss drugs (WLD) including glucagon-like peptide-1 agonists (GLP-1 agonists) are increasingly used for obesity to promote weight loss and insulin sensitivity. Currently, recommendations are to halt all WLD in pregnancy given undetermined safety profiles or previously identified te...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Kelly Mover, Eden Crowsey, Vanessa Hux, Terrika Jones, Suzanne Lababidi, Bryna Peplinski
Format:	Artigo
Język:	Inglês
Wydane:	SAGE Publishing 2025-01-01
Seria:	Women's Health Reports
Hasła przedmiotowe:	preconception weight loss gestational weight gain weight loss drug
Dostęp online:	https://www.liebertpub.com/doi/10.1177/26884844251401523
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!